92
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-κB

, MD &
Pages 372-376 | Received 20 Feb 2009, Accepted 28 Jul 2009, Published online: 01 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carl W. Oettinger & Martin J. D'souza. (2012) Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition. Journal of Microencapsulation 29:5, pages 455-462.
Read now

Articles from other publishers (6)

Jin Wang, Anatoly V. Grishin & Henri R. Ford. (2016) Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96. The Journal of Immunology 196:12, pages 5130-5137.
Crossref
V. G. Metelev, E. A. Kubareva & T. S. Oretskaya. (2013) Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides. Biochemistry (Moscow) 78:8, pages 867-878.
Crossref
Weiwei Zhang, Qi Sun, Xiaoli Gao, Yimin Jiang, Runtao Li & Jia Ye. (2013) Anti-Inflammation of Spirocyclopiperazinium Salt Compound LXM-10 Targeting α7 nAChR and M4 mAChR and Inhibiting JAK2/STAT3 Pathway in Rats. PLoS ONE 8:6, pages e66895.
Crossref
Riccardo V. D'Elia, Kate Harrison, Petra C. Oyston, Roman A. Lukaszewski & Graeme C. Clark. (2013) Targeting the “Cytokine Storm” for Therapeutic Benefit. Clinical and Vaccine Immunology 20:3, pages 319-327.
Crossref
Miroslav Pohanka. (2012) Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology. International Journal of Molecular Sciences 13:2, pages 2219-2238.
Crossref
Lennert Slobbe. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 609 651 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.